CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis. - Wikidata - wikimedia - TriplyDB

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

http://www.wikidata.org/entity/Q34485215

about

Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links Fibroblasts in fibrosis: novel roles and mediators The wound healing, chronic fibrosis, and cancer progression triad Tbx18 Regulates the Differentiation of Periductal Smooth Muscle Stroma and the Maintenance of Epithelial Integrity in the Prostate Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection Complex cellular composition of solitary fibrous tumor of the prostate.Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation.Prostatic fibrosis, lower urinary tract symptoms, and BPH Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion.CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling.Promising molecular targets and biomarkers for male BPH and LUTS Interfacial Adipose Tissue in Systemic Sclerosis.Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.Inflammation and prostate cancer: friends or foe?The senescence-associated secretory phenotype promotes benign prostatic hyperplasia.Role of PAR2 in the Development of Lower Urinary Tract Dysfunction.R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation.An immunohistochemical identification key for cell types in adult mouse prostatic and urethral tissue sections.CXCL12/CXCR4-Mediated Procollagen Secretion Is Coupled To Cullin-RING Ubiquitin Ligase Activation.

P2860

Q26782663-29059E11-50DD-40B8-AE87-D0434F94718F Q26998508-B8757ED4-4A2C-45CA-9055-BF44F1EFA1B1 Q27014616-B9BA6EB2-3DE2-474E-BE2D-AC54AA6D961D Q27312119-507FBA60-169D-4AA3-9927-974EA7426383 Q27321863-D3F203C0-1C33-4AF5-9530-72ABC5DFAB61 Q33412719-B45941CD-B1BF-4869-B090-5B901E101C72 Q33908275-27194E66-2EFD-4444-93E0-9E156B4B23AC Q34163024-5C900EB7-8FBA-4A22-B74D-8933E41017F5 Q34581160-260DE834-C08F-47C1-A344-E5E558FB243F Q34822091-6F7AEAF1-C601-4EA4-AEBE-1F1F46E96203 Q35798142-940E732D-4D5C-4028-8DB2-BA273D7E0287 Q36066095-5345937A-8288-42BF-AAF1-BDC1DD760E54 Q36081785-125AEABC-EAD2-4BDF-A8E7-D7EB6309F402 Q37364472-FF0FAC6C-B0F9-4F42-B897-7C806A5B8DAC Q37616390-B6033BEE-BA27-4919-AF61-93B0E5BAF8B6 Q38207592-B9BC78DD-FFAA-47A4-8657-83695DADFA82 Q38383521-93D98A8A-FDCE-4CB1-9E19-615626DEA183 Q41840130-EC145E40-E12B-4D8B-B421-39D757578E05 Q42253197-CD551FDF-2F87-4C22-BB26-FF952B34C0CF Q42368982-04055AAD-82C1-4882-B99E-39A332D2E80B Q46411486-87A4D329-D5CE-4F45-8AA0-66B2CF2435E6 Q50309115-AE1F5594-D9E3-43A0-9689-E596322F799A

P2860

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

http://www.wikidata.org/entity/Q34485215

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@ast

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@en

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@nl

type

label

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@ast

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@en

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@nl

prefLabel

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@ast

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@en

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@nl

P1433

Q34485215-3625A935-45E4-4EF2-864E-94EBEF7D5978

P1476

Q34485215-9FDDE5F2-CEC8-4D3C-A4D6-A9FFEABB6CA3

P2093

Q34485215-09819132-2D17-46A5-8EAE-14DE9E3383F0

Q34485215-1EAFF888-9C2D-4396-B0B6-49854FF8F8AD

Q34485215-74976AC5-9876-43F4-838D-A1D29C29A07A

Q34485215-A2459F6A-5963-4C54-8BCC-2B6EAA872A8B

Q34485215-C337EA2C-0659-4ED0-A694-7E73DC5B2557

P2860

Q34485215-05407CA7-B7F2-4C1D-BBC8-CBF3C1F54356

Q34485215-07DD5595-17F4-4A05-BE1D-D10DA77F7D9C

Q34485215-08450572-89F8-4FA3-BBE1-59360FAF38BD

Q34485215-0D7DC774-CC57-4473-93C6-0E2D165C4221

Q34485215-10F7D47F-AB23-4DB3-8392-D040C73FD086

Q34485215-150037BF-D1A5-450A-B2D3-30ACBB8D44AB

Q34485215-1856CD64-C99B-4C00-9C2F-EE642353D711

Q34485215-1B0A9C9F-15B8-4527-AA8A-1E6ABFBCD628

Q34485215-1C6512F2-63A5-4E1D-9DA4-28E7C2F169C2

Q34485215-20F12530-4A1E-43C3-87D6-D992E21F6B8D

P304

Q34485215-8F0528BD-B045-4284-8092-AA90FA1A9F53

P31

Q34485215-507BA28A-004D-49EC-81CA-C42EFEC8B77C

P356

Q34485215-EFC9BD54-3106-4BE5-BA36-05CF3E484699

P407

Q34485215-5FBF3C11-408E-4FD6-845E-81C5CB19497F

P433

Q34485215-AEF2AE61-FECF-46F0-B601-33AD22F06392

P478

Q34485215-CE2041BC-B258-4B36-9805-D3D873B093B8

P50

Q34485215-22F44200-32BB-46C2-B9D5-21037C2E9673

P577

Q34485215-D234BA34-2598-4E9A-BC84-55BB8606FEAE

P5875

Q34485215-48EC7846-39D2-4C08-910B-45229ECEAC38

P698

Q34485215-5692BFC4-57FE-4B32-9ABC-B507FD35298F

P932

Q34485215-056AC765-7E25-4C93-97E1-231BEDEFCF69

P356

JOURNAL.PONE.0049278

P1433

P1476

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

@en

P2093

Dafydd Thomas

http://www.w3.org/2001/XMLSchema#string

Jill A Macoska

http://www.w3.org/2001/XMLSchema#string

Mehrnaz Gharaee-Kermani

http://www.w3.org/2001/XMLSchema#string

Rohit Mehra

http://www.w3.org/2001/XMLSchema#string

Sathish Kasina

http://www.w3.org/2001/XMLSchema#string

P2860

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

Cellular and molecular mechanisms of fibrosis

The myofibroblast: one function, multiple origins

A new mathematical model for relative quantification in real-time RT-PCR

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor

Telomere shortening is an in vivo marker of myocyte replication and aging.

Quantitative morphometry of the adult human bladder.

Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia.

P304

e49278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0049278

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Bethany B Moore

P577

2012-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233746285

http://www.w3.org/2001/XMLSchema#string

P698

23173053

http://www.w3.org/2001/XMLSchema#string

P932

3500280

http://www.w3.org/2001/XMLSchema#string